This inventor holds 3 USPTO granted patents. Top assignee: Lg Life Sciences, Limited. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yuseong-gu, KR (2007)
- Taejeon, KR (2009 - 2010)
Company Filing History:
Years Active: 2007-2010
Title: Jae-Taeg Hwang: Innovator in Antiviral Research
Introduction
Jae-Taeg Hwang is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of antiviral research, particularly in the development of acyclic nucleoside phosphonate derivatives. His work has the potential to impact the treatment of viral infections, including hepatitis B.
Latest Patents
Hwang holds 3 patents related to his innovative research. His latest patents include the development of acyclic nucleoside phosphonate derivatives, which are useful as antiviral agents. These inventions focus on the preparation of derivatives and their pharmaceutically acceptable salts, which can be crucial in combating viral infections.
Career Highlights
Jae-Taeg Hwang is currently associated with LG Life Sciences, Limited, where he continues to advance his research in the pharmaceutical field. His work has garnered attention for its potential applications in medicine, particularly in the fight against hepatitis B virus.
Collaborations
Hwang has collaborated with notable colleagues, including Woo-Young Cho and Chung-Mi Kim. These partnerships have contributed to the success of his research and the development of innovative solutions in antiviral therapies.
Conclusion
Jae-Taeg Hwang's contributions to antiviral research through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile